House Slips Pay-For-Delay Ban Into War Bill

Law360, New York (July 2, 2010, 10:57 AM EDT) -- The U.S. House of Representatives has passed a measure banning patent settlements struck between brand-name and generic pharmaceutical companies to delay the release of generic drugs, in an effort to shave nearly $2 billion off government spending over the next decade.

The measure was added to offset war and education spending in H.R. 4899, the Supplemental Appropriations Act of 2010, which passed the House by a vote of 239-182.

The House bill amendment is modeled after S. 369, the Preserve Access to Affordable Generics Act, sponsored...
To view the full article, register now.